نتایج جستجو برای: bare metal stents

تعداد نتایج: 219934  

Journal: :The American journal of cardiology 2004
Esteban Escolar Gary S Mintz Myeong-Ki Hong Cheol Whan Lee Jae-Joong Kim Neal E Fearnot Seong-Wook Park Seung-Jung Park Neil J Weissman

To determine the relation of intimal hyperplasia thickness to stent size in nonpolymeric paclitaxel-coated stents, intravascular ultrasound was performed after stent implantation and at 6 months. Similar to bare metal stents, this study demonstrated that intimal hyperplasia thickness is independent of stent size. There was no deleterious effect of the increased concentration associated with usi...

2012
Iman Mohasseb Christian A Gericke Bruce Biccard Sripal Bangalore

In this correspondence we discuss the results of the meta-analysis by De Luca et al. (2012) in the Archives of Internal Medicine which found that late myocardial reinfarction and stent thrombosis is more common in drug-eluting stents than in bare-metal stents. We discuss the clinical implications of this paper for dual anti-platelet therapy which did not receive sufficient attention in the orig...

Journal: :Lancet 2008
Stephen D Wiviott Eugene Braunwald Carolyn H McCabe Ivan Horvath Matyas Keltai Jean-Paul R Herrman Frans Van de Werf William E Downey Benjamin M Scirica Sabina A Murphy Elliott M Antman

BACKGROUND Intracoronary stenting can improve procedural success and reduce restenosis compared with balloon angioplasty in patients with acute coronary syndromes, but can also increase the rate of thrombotic complications including stent thrombosis. The TRITON-TIMI 38 trial has shown that prasugrel-a novel, potent thienopyridine-can reduce ischaemic events compared with standard clopidogrel th...

Journal: :Circulation 2011
Robert W Yeh Sharon-Lise T Normand Robert E Wolf Philip G Jones Kalon K L Ho David J Cohen Donald E Cutlip Laura Mauri Aaron D Kugelmass Amit P Amin John A Spertus

BACKGROUND Drug-eluting stents (DES) for percutaneous coronary intervention decrease the risk of restenosis compared with bare metal stents. However, they are costlier, require prolonged dual antiplatelet therapy, and provide the most benefit in patients at highest risk for restenosis. To assist physicians in targeting DES use in patients at the highest risk for target vessel revascularization ...

2017
Benjamin D. Hunt Matthew A. Popplewell Huw Davies Lewis Meecham Hugh Jarrett Gareth Bate Margaret Grant Smitaa Patel Catherine Hewitt Lazaros Andronis Jonathan J. Deeks Andrew Bradbury

BACKGROUND Severe limb ischaemia (SLI) is defined as the presence of rest pain and/or tissue loss secondary to lower extremity atherosclerotic peripheral arterial disease. The superficial femoral and popliteal arteries are the most commonly diseased vessels in such patients and are being increasingly treated using endovascular revascularisation techniques. However, it is currently unknown wheth...

Journal: :Circulation journal : official journal of the Japanese Circulation Society 2015
Hannes Lindemann Udo Sechtem Peter Ong

recurrent or ongoing angina after successful percutaneous coronary intervention (PCI) with metal stents in the absence of any relevant re-stenosis may be caused by functional coronary abnormalities.2 In the present study we describe the case of a patient with previous successful BVS implantation who was referred for repeated coronary angiography due to recurrent angina and subsequently underwen...

Journal: :European heart journal 2010
Martin Troubil Vladimir Lonsky Santavy Petr

disease. N Engl J Med 2009;360:961–972. 7. King SB III, Kosinski AS, Guyton RA, Lembo NJ, Wentraub W for the Emory Angioplasty versus Surgery Trial (EAST) Investigators. Eight-year mortality in the Emory Angioplasty Versus Surgery Trial (EAST). J Am Coll Cardiol 2000;35: 1116–1121. 8. Bypass Angioplasty Revascularization Investigation (BARI) investigators. Comparison of coronary bypass surgery ...

2017
Lawrence Ang Omid Behnamfar Samhita Palakodeti Felice Lin Ali Pourdjabbar Mitul P. Patel Ryan R. Reeves Ehtisham Mahmud

BACKGROUND Elevated fibrinogen is associated with short-term major adverse cardiovascular events (MACE) after percutaneous coronary intervention, but the relation with late MACE is unknown. METHODS AND RESULTS Baseline demographics and 2-year MACE were recorded among subjects undergoing nonemergent percutaneous coronary intervention. A total of 332 subjects (66.6±19.5 years, 69.9% male, 25.3%...

Journal: :Journal of the American College of Cardiology 2014
Fernando Alfonso Maria Jose Pérez-Vizcayno Alberto Cárdenas Bruno García Del Blanco Bernhard Seidelberger Andrés Iñiguez Manuel Gómez-Recio Mónica Masotti M Teresa Velázquez Juan Sanchís Arturo García-Touchard Javier Zueco Armando Bethencourt Rafael Melgares Angel Cequier Antonio Dominguez Vicente Mainar José R López-Mínguez José Moreu Vicens Martí Raúl Moreno Pilar Jiménez-Quevedo Nieves Gonzalo Cristina Fernández Carlos Macaya

OBJECTIVES This study sought to compare the efficacy of drug-eluting balloons (DEB) with that of everolimus-eluting stents (EES) in patients with bare-metal stents (BMS) in-stent restenosis (ISR). BACKGROUND Treatment of patients with ISR remains a challenge. METHODS This was a prospective, multicenter, randomized trial comparing DEB with EES in patients with bare-metal stents (BMS) in-sten...

2011
Robert W. Yeh Sharon-Lise T. Normand David J. Cohen Laura Mauri John A. Spertus

Background—Drug-eluting stents (DES) for percutaneous coronary intervention decrease the risk of restenosis compared with bare metal stents. However, they are costlier, require prolonged dual antiplatelet therapy, and provide the most benefit in patients at highest risk for restenosis. To assist physicians in targeting DES use in patients at the highest risk for target vessel revascularization ...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید